Literature DB >> 17541332

Statins and blood pressure: is there an effect or not?

Pantelis A Sarafidis1, Angeliki I Kanaki, Anastasios N Lasaridis.   

Abstract

In addition to the lipid-lowering effects of statins, several basic and clinical studies in recent years have examined the effects of these agents on other cardiovascular parameters. Some of these studies investigated the general impact of a statin on blood pressure (BP) among various other factors, while others were specifically designed to determine this effect. Data from animal studies are conflicting but the majority of human studies in the field report a beneficial effect, and most available statin compounds are reported to lower BP levels. Recent clinical studies using ambulatory BP measurements support these findings. Although the exact actions of statins involved in this effect are unknown, several possible mechanisms can be hypothesized. This review summarizes existing data on the effect of statins on BP, aiming to give an overview of the current knowledge and to provide perspectives for future research in the field.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541332      PMCID: PMC8109905          DOI: 10.1111/j.1524-6175.2007.06625.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  57 in total

Review 1.  The discovery and development of HMG-CoA reductase inhibitors.

Authors:  A Endo
Journal:  J Lipid Res       Date:  1992-11       Impact factor: 5.922

2.  Lowering of elevated ambulatory blood pressure by HMG-CoA reductase inhibitors.

Authors:  Laura Terzoli; Luca Mircoli; Roberta Raco; Alberto U Ferrari
Journal:  J Cardiovasc Pharmacol       Date:  2005-09       Impact factor: 3.105

3.  Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.

Authors:  U Laufs; V La Fata; J Plutzky; J K Liao
Journal:  Circulation       Date:  1998-03-31       Impact factor: 29.690

4.  Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial.

Authors:  Antti Jula; Jukka Marniemi; Risto Huupponen; Arja Virtanen; Merja Rastas; Tapani Rönnemaa
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

5.  Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia.

Authors:  C Borghi; M G Prandin; F V Costa; S Bacchelli; D Degli Esposti; E Ambrosioni
Journal:  J Cardiovasc Pharmacol       Date:  2000-04       Impact factor: 3.105

6.  Pravastatin decreases blood pressure in hypertensive and hypercholesterolemic patients receiving antihypertensive treatment.

Authors:  Hiroaki Kawano; Katsusuke Yano
Journal:  Circ J       Date:  2006-09       Impact factor: 2.993

7.  HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.

Authors:  S Wassmann; U Laufs; A T Bäumer; K Müller; K Ahlbory; W Linz; G Itter; R Rösen; M Böhm; G Nickenig
Journal:  Hypertension       Date:  2001-06       Impact factor: 10.190

8.  Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

Authors:  Peter S Sever; Neil R Poulter; Björn Dahlöf; Hans Wedel; Rory Collins; Gareth Beevers; Mark Caulfield; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

9.  Simvastatin in the treatment of hypercholesterolemia in elderly patients.

Authors:  R Antonicelli; G Onorato; P Pagelli; L Pierazzoli; E Paciaroni
Journal:  Clin Ther       Date:  1990 Mar-Apr       Impact factor: 3.393

10.  Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet.

Authors:  Giuseppe Derosa; Amedeo Mugellini; Leonardina Ciccarelli; Roberto Fogari
Journal:  Clin Ther       Date:  2003-04       Impact factor: 3.393

View more
  3 in total

1.  Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial.

Authors:  Beatrice A Golomb; Joel E Dimsdale; Halbert L White; Janis B Ritchie; Michael H Criqui
Journal:  Arch Intern Med       Date:  2008-04-14

2.  Proinflammation and hypertension: a population-based study.

Authors:  Vanhala Mauno; Kautiainen Hannu; Kumpusalo Esko
Journal:  Mediators Inflamm       Date:  2008-12-30       Impact factor: 4.711

3.  Predictors of blood pressure response to angiotensin receptor blocker/diuretic combination therapy: a secondary analysis of the irbesartan/hydrochlorothiazide blood pressure reductions in diverse patient populations (INCLUSIVE) study.

Authors:  Elijah Saunders; Greg Cable; Joel Neutel
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-01       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.